Molecular Data

Molecular Data Debt

Delisted

The Debt of Molecular Data (MKD) as of Oct 29, 2026 is 178.08 M CNY. In the previous year, Debt was 191.16 M CNY — a change of -6.84% (lower).

Debt

178.08 MCNY

YoY

-6.84%

Last updated:

In 2020, Molecular Data's total debt was 178.08 M CNY, a -6.84% change from the 191.16 M CNY total debt recorded in the previous year.

The Molecular Data Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
220.33 M CNY
Jan 1, 2018
205.70 M CNY
Jan 1, 2019
191.16 M CNY
Jan 1, 2020
178.08 M CNY
The Molecular Data Debt history
YEARDebtYoY
178.08 MCNY-6.84%
191.16 MCNY-7.07%
205.70 MCNY-6.64%
220.33 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Molecular Data Stock analysis

What does Molecular Data do? Molecular Data Inc. is a leading technology company specializing in the use of big data, artificial intelligence (AI), and blockchain technology in the chemical and pharmaceutical industry. The company was founded in 2014 and is headquartered in Shanghai, China. Molecular Data Inc. has a comprehensive database consisting of millions of chemical compounds, which aids chemists, pharmaceutical companies, and researchers in identifying, exploring, and developing new drugs. The company places great importance on integrating data and technologies to accelerate and improve drug development. Molecular Data Inc. provides cloud-based solutions based on the analysis of big data through AI algorithms and blockchain technology. It offers platforms, as well as consulting and training services, to support customers in efficiently utilizing the platforms. The company's main products include the MDL platform, which enables the integration of data, knowledge, and algorithms to accelerate drug development processes. The MDL platform is a cloud-based system that provides access to a database of millions of compounds and allows users to receive real-time results. Molecular Data Inc. also offers a blockchain-based platform for the chemical and pharmaceutical industry, enhancing the transparency and security of data and information. The platform facilitates secure data exchange between different companies and regulatory authorities, providing improved control and monitoring of data. Another important service provided by Molecular Data Inc. is consulting and training for companies in implementing big data, AI, and blockchain into their workflows. The company aims to equip its customers with the necessary skills and knowledge to optimize their business processes and increase competitiveness. Molecular Data Inc. is divided into several divisions to ensure efficient collaboration and product development. These divisions include research and development, sales and marketing, finance and administration, and information technology. The company strives to expand its business through strategic partnerships and acquisitions. It has already completed several acquisitions to strengthen its expertise in big data, AI, and blockchain. Through these strategic measures, the company has been able to offer its customers a comprehensive range of products and services to enhance performance and increase competitiveness. Overall, Molecular Data Inc. is a significant company in the chemical and pharmaceutical industry that specializes in the integration of data and technologies to enhance process efficiency and speed. The company aims to strengthen its position as a market leader through innovation and strategic partnerships. Molecular Data is one of the most popular companies on Eulerpool.

Debt Details

Understanding Molecular Data's Debt Structure

Molecular Data's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Molecular Data's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Molecular Data’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Molecular Data’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Molecular Data stock

Debt of Molecular Data is 178.08 M CNY in 2020.

Debt of Molecular Data changed from 191.16 M CNY to 178.08 M CNY, representing a -6.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Molecular Data since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Molecular Data historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Molecular Data

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Molecular Data